← Back to Search

Light Therapy

Low-Level Light Therapy for Dry Eye Syndrome (ELOM Trial)

N/A
Waitlist Available
Led By Eric R Ritchey, OD, PhD
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights

ELOM Trial Summary

This trial will investigate how light therapy affects the glands in the eyes that produce oil and if it can help treat dry eye disease. Participants will receive 3 15-min sessions of light therapy & meibum samples will be taken before/after.

Eligible Conditions
  • Meibomian Gland Dysfunction
  • Dry Eye Syndrome

ELOM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Meibum protein composition
Secondary outcome measures
Meibum lipid composition
Other outcome measures
Non-invasive tear break up time
Tear lipid layer thickness
Tear meniscus height

ELOM Trial Design

1Treatment groups
Experimental Treatment
Group I: Low-Level Light TherapyExperimental Treatment1 Intervention
All subjects will receive 3 15-minute treatments of low level light therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Red Low-Level Light Therapy
2023
N/A
~30

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
148 Previous Clinical Trials
47,568 Total Patients Enrolled
University of LouisvilleOTHER
339 Previous Clinical Trials
76,650 Total Patients Enrolled
Eric R Ritchey, OD, PhDPrincipal InvestigatorThe University of Houston College of Optometry
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Red Low-Level Light Therapy (Light Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05859295 — N/A
Meibomian Gland Dysfunction Research Study Groups: Low-Level Light Therapy
Meibomian Gland Dysfunction Clinical Trial 2023: Red Low-Level Light Therapy Highlights & Side Effects. Trial Name: NCT05859295 — N/A
Red Low-Level Light Therapy (Light Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05859295 — N/A
Meibomian Gland Dysfunction Patient Testimony for trial: Trial Name: NCT05859295 — N/A
~15 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top